Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Moreaux
A High-Risk Signature for Patients With Multiple Myeloma Established From the Molecular Classification of Human Myeloma Cell Lines
Haematologica
Hematology
CeVi: A UNIQUE CRYOPRESERVED HUMAN VIABLE CELL COLLECTION FROM LYMPHOMA PATIENTS, a CALYM INITIATIVE TO ACCELERATE INNOVATION AND ITS TRANSFER TO LYMPHOMA FIELD
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Lack of BRAF V600E Mutation in Human Myeloma Cell Lines Established From Myeloma Patients With Extramedullary Disease
Blood Cancer Journal
Oncology
Hematology
Human Myeloma Cell Line (KHM-4) Established From a Patient With Multiple Myeloma Associated With Hyperammonemia.
Internal Medicine
Internal Medicine
Medicine
CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
The Singapore Myeloma Study Group Consensus Guidelines for the Management of Patients With Multiple Myeloma
Singapore Medical Journal
Medicine
High-Risk Multiple Myeloma: Different Definitions, Different Outcomes?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Management of Older Patients With Multiple Myeloma
Blood Reviews
Oncology
Hematology
